US Orthopedics Market Size to Reach USD 25.71 Billion By 2034

The global US orthopedics market size accounted for USD 7.03 billion in 2024 and is predicted to touch around USD 25.71 billion by 2034, growing at a CAGR of 13.84% from 2025 to 2034.

Highlights of the US Orthopedics Market

• By therapeutic application, the joint replacement implants segment is dominating the U.S. orthopedics market.
• By therapeutic application, the trauma fixation devices segment is the fastest-growing one in the market. 
  

Industry Valuation and Growth Rate Projection

The U.S. orthopedics market consists of orthopedic surgery, or orthopedics, which is a kind of surgery that has to do with conditions involving the musculoskeletal system, encompassing bones, joints, muscles, ligaments, and tendons. Orthopedic surgeons utilize both surgical and nonsurgical ways to treat musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, and tumors. Some of the key types of orthopedic subspecialties are sports medicine, joint replacement, spine surgery, trauma surgery, hand surgery, and foot and ankle surgery.
The benefits offered by orthopedics include pain management, improved movement, lowered risk of further injury, faster recovery, and better quality of life. The use of AI during and after the surgery is increasing, moving the market further.

• The study by HSS involved 212 adult spine surgery patients, and 1,211 pedicle screws were placed in their bodies, using either robotics for 108 individuals or augmented reality for 104 patients between June 2020 and October 2023.

US Orthopedics Market: Stats and Figures

• As of now, approximately 790,000 knee replacement surgeries are performed in the U.S. every year.
• Around 60% of orthopedic surgeons are sub-specialists, and the others include general orthopedic surgeons with a sub-specialty interest or general orthopedic surgeons.
• According to the ASR 2025 Annual Report, 230,159 lumbar and 112,683 cervical spine procedures were performed between the years 2015 and 2023.
• In 2023, the count of orthopedic surgeons in the U.S. was 19,344.
• Between 2000 to 2020, Inflation-adjusted Medicare reimbursement for foot and ankle surgery declined by 30%.

How AI Has Benefitted the US Orthopedics Market

The U.S. orthopedics market has tremendously benefited from AI. The surgical robots driven by AI can help surgeons with complex procedures such as joint replacements and spinal surgeries. Using AI, personalized implants based on a patient’s anatomy and functioning can be formulated, leading to a fit enhancement and smoother functions of the implants. There is an availability of remote monitoring systems that can track patient progress and predict probable difficulties, while reducing the hospital visits for the patients and maintaining the steadiness of care. The research ability can be accelerated in orthopedics through AI by studying large datasets and recognizing patterns that may not be noticeable to human researchers.

US Orthopedics Market Dynamics

What are the US Orthopedics Market Drivers?

The U.S. orthopedics market is driven by increasing musculoskeletal disorders, advances in technology, rise in the demand for orthopedic surgeries. The conditions, including obesity, deskbound lifestyles, and an enlarged incidence of work-related injuries, need orthopedic surgeries and the use of assistive devices. Marginally invasive surgical techniques and Robotic-supported surgery are grabbing attention in the US. People here are asking for the use of technologically advanced implants and devices that can last for a long time.

What are the U.S. Orthopedics Market Restraints?

The U.S. orthopedics market is held back because of the restraints, like a shortage of workforce and higher costs and compensation. There is an immense shortage of orthopedic surgeons, and it will probably be the same as the older surgeons are retiring, and the number of new surgeons is inadequate. This is having an impact on the surgeons as the surgeries to be performed are more than the doctors. Also, the new technologies are filled with intricacies and require training and skill development, which is proving to be a challenge now.

The orthopedic surgeons can perform surgeries using devices at a quicker pace. The cost of orthopedic devices, though, is way too much. This creates a hindrance for some patients as they cannot access them. At the same time, the procedures required to be performed are heavy on the pockets for certain patient populations. The reimbursement policies for new technologies may not be completely supportive, and their adoption can thus pose a challenge.

What are the U.S. Orthopedics Market Opportunities?

The U.S. orthopedics market has a lot of opportunities ahead. People are highly participating in sports and recreational activities, which is increasing the demand for orthopedic care and related devices, as the possibilities of sports-related injuries may grow. The Ambulatory Surgical Centers (ASCs) are largely being chosen for orthopedic procedures as they are a cost-effective alternative to hospitals. The companies are thus creating products and services personalized to the ASC site. The market is looking at a rise in the number of mergers and acquisitions by firms as they want to expand their presence, creating prospects for market growth.

Industry Leader Announcements

• John Naybour, founder and CEO of Eventum Orthopaedics:

While highlighting the need to improve the outcomes of surgeries, Naybour said, “Total knee replacement is a common operation, yet two out of ten patients are not happy with the results, and one in ten is very dissatisfied. Our mission is to improve success rates by providing data to help surgeons make better clinical decisions. The device has been well received by the orthopaedic profession, and we are excited to be rolling it out internationally.”

Segmental Insights

Therapeutic Application Insight

The U.S. orthopedics market is being dominated by the joint replacement implants segment. This is happening because of the escalating occurrence of osteoarthritis and patients choosing joint replacements more often. The most common risk factor for osteoarthritis is obesity in patients. The US has seen people with obesity increasing gradually. This is leading to the need for joint replacements more than ever. Even patients prefer joint replacements as they take less recovery time. All the more, women tend to have a greater prevalence of osteoarthritis, which creates greater demand for joint replacement implants.

The trauma fixation devices segment is growing rapidly in the U.S. orthopedics market. The advances in orthopedic surgery are the most important reason behind the same. In the US, biocompatible materials are growing in recognition for trauma fixation devices as they can become one with the body, reduce complications, and possibly wipe out the need for implant removal surgeries. The availability of three-dimensional (3D) printing technology has the capability to improve access to external fixation devices in orthopedics. Smart implants in trauma fixation devices are becoming a popular choice as they can enhance patient care and potentially decrease healthcare costs. These implants have sensors in them that can offer real-time data, and looking after a patient becomes easier for the surgeons.

The spinal fusion devices segment is growing, as the adoption of ambulatory surgical centers is on the rise. The ambulatory surgical centers are performing spinal fusion procedures on a larger scale, which helps save costs in comparison with conventional in-hospital settings. The degenerative disc disease, such as arthritis, is occurring more frequently as the number of elderly people increases. This calls for more spinal fusion surgeries. Another reason is the spinal injuries, like Traumatic Spinal Cord Injuries (TSCI), whose cases are estimated to be 54 per million people each year in the US. This adds up to more demand for spinal fusion procedures for the treatment of spinal issues.

The plates and screws segment is growing in the US as a result of the increasing incidence of bone fractures, developments in surgical techniques, and a rising demand for minimally invasive procedures. Minimally invasive surgery (MIS) with plates and screws is seeing growth due to its popularity. These procedures cause less pain, and the recovery time taken by them is quicker. The technological innovations in surgical instruments and imaging are leading to more detailed procedures with minor incisions.

There is a huge requirement for orthopedic surgeries, and the bone plates segment is thus boosted. The US is in the front row when it comes to medical inventions. Bone plates are no different from them. They are utilized for fracture fixation and to encourage bone healing. Because of them, the bone fragments get support and become stable. Additionally, the adoption of advanced orthopedic implants, including bone plates, is supported by the robust healthcare infrastructure and reimbursement system.

The bone screws segment can be seen developing in the US. There is an availability of bioabsorbable bone screws, which perish naturally over time, and there is no need for a second surgery to remove the implant. This is thus becoming a popular choice among consumers. Some more advancements have paved the way for the development of stronger, more biocompatible bone screws, including titanium and its alloys, as they enable impeccable strength. While performing dental procedures, bone screws can be employed to even out implants and other dental devices.

Recent Developments in the US Orthopedics Market

• In June 2025, SmartTRAK joined hands to co-market with Foot Innovate for the unveiling of a trailblazing F&A market research solution that merges robust analytics with real-world surgeon experience.
• In June 2025, Zimmer Biomet began working in partnership with Think Surgical to entirely distribute a wireless handheld robotic knee surgery device, Rosa.
• In January 2025, SCA Health signed the acquisition of OrthoAlliance for an approximate value of $1.4 billion.

Competitive Landscape

The US orthopedics market is highly competitive, with leading healthcare companies such as Medtronic, Stryker, Globus Medical, DePuy Synthes, Zimmer Biomet, Orthofix, Smith+Nephew, Arthrex, Enovis, Alphatec, NuVasive, Wright Medical, and Sharma Orthopedic holding the highest market share. Emerging medical firms also play a crucial role by fostering a dynamic and evolving competitive landscape.

The market is dominated by several healthcare companies renowned for their significant contributions to orthopedic research and treatment. Based on recent data, the top three leading companies are:

• Company Name: Medtronic plc
  
• Year of Incorporation: 1949
  
• Headquarters: Minnesota, United States

Medtronic plc, a medical technology company, develops, manufactures, and retails medical devices and solutions. The products it provides are heart failure, diseases of the coronary artery, peripheral vascular and neurological diseases, spine and musculoskeletal disorders, and diseases of the ear, nose, and throat. Its products reach hospitals, third-party healthcare providers, clinics, institutions, and more. The countries where the company offers its products are Asia Pacific, Europe, the Americas, the Middle East, and Africa.

The yearly revenue of Medtronic was accounted to be $32,364,000 in 2024.

• Company Name: Stryker Corp
• Year of Incorporation: 1946
• Headquarters: Michigan, United States

Stryker Corp is a medical technology company. Its major products include orthopedic implants, surgical equipment, surgical navigation systems, emergency medical equipment, intensive care disposable products, and more. In addition to this, it provides neurosurgical equipment, neurovascular and spinal devices, and medical devices. The company trades its products by means of subsidiaries, branches, third-party dealers, and distributors in the Americas, Europe, Asia-Pacific, the Middle East, and Africa regions.

The yearly revenue of Stryker stood at $22,595,000 in 2024.

• Company Name: Globus Medical Inc.
• Year of Incorporation: 2003
• Headquarters: Pennsylvania, United States

Globus Medical Inc. is a medical device company. The company deals in implantable devices, biologics, accessories, and surgical instruments used for various spinal, orthopedic, and neurosurgical procedures. The main products of this firm encircle ankle fracture systems, vertebral augmentation systems, cannula kits, clavicle fracture systems, distal radius fracture systems, and proximal tibia fracture systems. It also provides computer-assisted intelligent systems that are designed to enrich surgeons’ capabilities and restructure surgical procedures. The distribution of products takes place directly and through a network of distributors located in the US and other countries.

The yearly revenue of Globus Medical was positioned at $2,519,355 in 2024.